Here, we have shown evidence from experimental murine GBM models and patient GBM samples highlighting the role of infiltrating immune cells and their potential contributions to checkpoint PD1-PDL1 induced immune suppression in GBM. The gene discussed is CD274; the disease is glioblastoma.